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Background. Microvascular dysfunction and microthrombi formation are believed to contribute to development of early
brain injury (EBI) after aneurysmal subarachnoid hemorrhage (SAH). Objective. This study aimed to determine (i) extent of
microthrombus formation and neuronal apoptosis in the brain parenchyma using a blood shunt SAH model in rabbits; (ii)
correlation of structural changes in microvessels with EBI characteristics. Methods. Acute SAH was induced using a rabbit shunt
cisterna magna model. Extent of microthrombosis was detected 24 h post-SAH (𝑛 = 8) by fibrinogen immunostaining, compared
to controls (𝑛 = 4). We assessed apoptosis by terminal deoxynucleotidyl transferase nick end labeling (TUNEL) in cortex and
hippocampus. Results. Our results showed significantly more TUNEL-positive cells (SAH: 115 ± 13; controls: 58 ± 10; 𝑃 = 0.016)
and fibrinogen-positive microthromboemboli (SAH: 9 ± 2; controls: 2 ± 1; 𝑃 = 0.03) in the hippocampus after aneurysmal SAH.
Conclusions.We found clear evidence of early microclot formation in a rabbit model of acute SAH.The extent of microthrombosis
did not correlate with early apoptosis or CPP depletion after SAH; however, the total number of TUNEL positive cells in the
cortex and the hippocampus significantly correlated with mean CPP reduction during the phase of maximum depletion after SAH
induction. Both microthrombosis and neuronal apoptosis may contribute to EBI and subsequent DCI.
1. Introduction
Aneurysmal subarachnoid hemorrhage (SAH) is a devas-
tating cerebrovascular disease with high mortality and dis-
ability rates [1]. Intensive research in recent years revealed
many different causes of SAH, including cerebral vasospasm,
early brain injury (EBI) mediated by impaired microcircula-
tory function, microthrombosis, cortical spreading depres-
sion, oxidative stress, inflammation, and apoptosis. All of
these conditions cause delayed cerebral ischemia (DCI)
and thereby influence clinical outcome [1–6]. However, the
relationship of microthrombi formation to early brain injury
and neuronal apoptosis after SAH still remains unclear. To
model the physiological situation in humanswith aneurysmal
SAH [7], this study investigated the association between early
injury after SAH, microclot formation, and apoptosis in an
extra-ntracranial blood shunt model in the rabbit.
2. Materials and Methods
2.1. Study Design. The study was incorporated as a sub-
project of ongoing experimental studies and performed in
accordance with the National Institutes of Health guidelines
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for the care and use of experimental animals and with the
approval of the Animal Care Committee of the Canton
of Bern, Switzerland (approval no. 107/09). Of 12 three-
month-old female New Zealand rabbits weighing 3.3–4.6 kg,
four animals served as sham-operated controls. In eight
animals, experimental SAH was performed as described
below. The animals were housed in groups (two to four
animals per cage) at 22–24∘C under a 12-hour light-dark
cycle with unrestricted access to food and tap water. All
surgical procedures were performed under sterile conditions
at the Experimental Surgical Institute, Department of Clinical
Research, Bern University Hospital, Bern, Switzerland. A
veterinary anesthesiologist monitored the animals during
surgery and throughout anesthetic recovery.
2.2. Anesthesia, Clinical Observation, and Sacrifice. Induc-
tion of general anesthesia was performed by subcutaneous
administration of ketamine (30mg/kg; Ketalar, 50mg/mL,
Pfizer, Zurich, Switzerland) and Xylazine (6mg/kg; Xylapan
20mg/mL, Vetoquinol, Bern, Switzerland) and continued
intravenously. Humidified oxygen was provided to the spon-
taneously breathing animals. The animals underwent clinical
observation during anesthetic recovery (first three hours) and
from then on every six hours. Euthanasia was performed
24 hours post-SAH induction under the same anesthesia
as previously described, by intra-arterial bolus injection of
sodium thiopental (40mg/kg) (Pentothal, Ospedalia AG,
Hu¨nenberg, Switzerland).
2.3. SAH Induction, Instruments, and Data Acquisition. The
intracerebral pressure- (ICP-) controlled blood shunt model
was used to induce SAHas described previously [7, 8]. Briefly,
the cisterna magna was punctured with a pediatric spinal
access needle (22G × 40mm) and connected via pressure
tube and interposed three-way stopcock to the subclavian
artery. The three-way stopcock was used for blood pressure
measurement and to control bleeding. Neuromonitoring
including an ICP monitor catheter tip (OLM Intracranial
Pressure Monitoring Kit, Camino, Model 110-4B, Camino
Laboratories, San Diego, CA, USA) and two laser-Doppler
flowmetry fine needle probes (MNP110XP, 0.48mmdiameter,
Oxford Optronix Ltd., Oxford, UK) were positioned in the
olfactory bulb and bilateral frontal lobe according to outer
skull landmarks [9]. Standard cardiovascular monitoring
(mean arterial blood pressure (MABP), heart rate, electrocar-
diogram, end-tidal CO
2
, and SaO
2
) was performed at a sam-
pling rate of 100Hz (Datex S5 Monitor GE Medical Systems
Switzerland, Glattbrugg, Switzerland), transferred via the
analog output interface to an analog-digital converter/data
logger, stored (Biopac MP100 and acknowledge version 3.8.1;
BIOPAC Systems, Inc., Goleta, CA, USA), and processed
for preanalysis using scripting software (Mathworks Inc,
Natick,MA,USA). Pressures were zeroed at heart level before
and after each session, and pressure calibration of the AD
converter and data-logging system was done once before the
series started.
SAH was initiated by opening the blood shunt to let
blood stream into the atlantooccipital cistern under arterial
pressure. After opening the shunt, ICP increased until it
reached a plateau. If this plateau phase was maintained for
more than 10 seconds, the shunt was closed. The shunt
was also closed if ICP decrease occurred spontaneously (no
later than 30 seconds from start of the plateau phase—we
therefore did not allow for potential rebleeding). Control
animals underwent frontal osteotomy with ICP and cerebral
blood flow (CBF) monitoring placement, as well as puncture
of the cisterna magna without blood shunting. MABP, ICP,
and bilateral regional cerebral blood flow rCBFwere recorded
for 5minutes before (baseline) and 20minutes after initiation
of SAH (steady state).
2.4. Tissue Processing, Histology, and Immunohistochemistry.
Intracardiac perfusion-fixation was carried out 24 hours
after SAH-induction at room temperature with 400mL of
0.1M phosphate-buffered solution (PBS) followed by 400mL
fixative (4% paraformaldehyde in 0.1M PBS, pH 7.3). Brains
were removed from the skull and cut into four blocks between
the forebrain (olfactory bulb) and cerebellum, embedded in
paraffin, and cut into consecutive 7 𝜇m sections. The cut
surface of block one was placed through the cortical punch
defect of the ICP and rCBF probes.The first section of blocks
two to four was stained with hematoxylin and eosin, and
the most representative fields containing the hippocampus
and basal cortex were selected for additional cuts of ten con-
secutive sections used for immunohistochemical analysis in
order to analyze the same subsection to eliminate bias. Apop-
tosis was detected using terminal deoxynucleotidyl trans-
ferase deoxyuridine triphosphate (dUTP) nick end labeling
(TUNEL, Roche Diagnostics AG, Rotkreuz, Switzerland) as
described above [7]. Quantitative analysis of apoptosis was
performed within predefined regions of interest (ROI) of
300 𝜇m × 300 𝜇m on coronal sections for each hemisphere
(Figure 1(b)). Thereby, 9 ROIs were used for analysis of
apoptosis in the basal cortex (9 × 300 𝜇m × 300𝜇m) and 3
ROIs along the hippocampal sectors CA1 and CA3 with (3
× 300 𝜇m × 300 𝜇m). Nuclei were counterstained with DAPI
(Roche Diagnostics AG, Basel, Switzerland). Slides were
visualized under a fluorescent microscope operating with a
digital camera (Olympus BX 51, Olympus, Hamburg, Ger-
many) using 2, 10, and 20x magnifications. Thereby, TUNEL
red, FJB green, and DAPI blue were excited at 570–620 nm
(maximum 580 nm), 450–490 nm (maximum 480 nm), and
340–380 nm (maximum 350 nm), respectively. The extent of
microthrombosis was detected by fibrinogen immunohisto-
chemistry using the Leica Bond III IHC staining system and
analyzed in a blinded manner according to the schematic
drawing depicted in Figure 1. For the fibrinogen immunohis-
tochemistry, heat-induced epitope retrieval was carried out at
95∘C for 20minutes, followed by incubationwith the primary
antibody (polyclonal fibrinogen sheep anti-rabbit antibody;
Acris, AP08879PU-N, 1:2󸀠000, Herford, Germany) and sec-
ondary antibody (biotin-SP-conjugated AffiniPure donkey
anti-sheep antibody; Jackson ImmunoResearch Laboratories,
713-065-003, 1:1󸀠000, West Grove; USA), followed by incuba-
tion with a streptavidin-conjugated horseradish peroxidase
reagent (Streptavidin-HRP, Leica Biosystems, RE7104).
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Figure 1: Microclot formation analyzed in the hippocampus and cortex. (a) Schematic drawing of regions used for analysis of fibrinogen
immunostained microclots in the hippocampus (red bar) and the cortex (blue bar). (b) Specific regions of interest (ROI) from the
hippocampus and cortex used for dimensional analysis.
2.5. Statistical Analysis. Data were analyzed and visualized
using IBM SPSS statistical software Version 21.0 (IBM Corp.,
New York, NY, USA) and processed for preanalysis using
Matlab scripting software (Mathworks Inc., Natick, MA,
USA). Values were expressed as mean ± SEM.The differences
between the normally distributed data of two groups were
analyzed by Student’s 𝑡-test and among three or more groups
by one-way ANOVA, respectively, with Bonferroni post hoc
testing. ANOVA regression analysis was used for calculation
of correlations between effects of SAH on the CPP and
the number of fibrinogen positive microvessels and the
TUNEL-positive cells.The strength of linear correlations was
expressed by the linear regression coefficient (reg coeff 𝑟) and
its squared value 𝑟2. A significance level of 𝑃 < 0.05 was
applied to all tests.
3. Results
3.1. Gross Examination of Brain and Pathophysiology. There
was no mortality in this study. In general, the mortality
rate is about 20%–30% due to respiratory arrest or severe
bradycardia at the time of acute SAH [8].There were no signs
of cerebrospinal fluid leakage along the frontal osteotomy
sites or at the site of nuchal cisterna magna puncture (data
not shown). Twenty-four hours after SAH, rabbits (𝑛 =
8) demonstrated extensive coagulated diffuse subarachnoid
blood in the chiasmatic, basal, prepontine cisterns, and
cistern magna. No subarachnoid blood was observed in
control animals (𝑛 = 4). All SAH animals demonstrated
marked increases in ICP (6.2 ± 1.7mmHg baseline versus
49.6 ± 11.9mmHg peak; 𝑃 < 0.001) with a corresponding
decrease in bilateral rCBF (mean of both hemispheres: 36.3±
20.3% from baseline, 𝑃 < 0.001) and the CPP (32.3 ±
15.0% of baseline, 𝑃 < 0.001) within the first three minutes
after induction of SAH. The ICP returned within 20 minutes
to a steady state that was slightly higher than baseline but
was not statistically different from baseline values (baseline:
6.2 ± 1.7mmHg, steady state: 19.4 ± 4.3mmHg; 𝑃 = 0.051).
Accordingly, both rCBF and CPP recovered to a state that
was not significantly below baseline levels (mean of both
hemispheres, rCBF: 76.8 ± 15.2% of baseline, 𝑃 = 0.18; CPP:
81.2 ± 9.6% of baseline, 𝑃 = 0.15). The mean arterial blood
pressure remained unchanged throughout. A summary of
pathophysiological characteristics is provided in Table 1.
3.2. Immunohistochemistry and Analyses. Fibrinogen stain-
ing showed distinct microclot formation in vessels of the
hippocampus (Figures 2(a) and 2(c)) and cerebral cortex
(Figures 2(b) and 2(d)) after SAH ((a), (b)) compared to
control animals ((c), (d)). Immunohistochemistry analysis
revealed a significant increase of the number of TUNEL-
positive cells in both cerebral cortex and hippocampus
(Figure 3(a)). Namely, there were 68 ± 8 TUNEL-positive
cells in the cortex after SAH compared to 36 ± 2 cells in the
control animals (differences between means 32 ± 11; 𝑃 =
0.017). In the hippocampus, there were 115 ± 13 TUNEL-
positive cells after SAH compared to 58 ± 10 positive cells
in the control animals (differences between means 58 ± 20;
𝑃 = 0.016). Taking into account the differences in the density
of neurons in the hippocampus and the cerebral cortex,
immunohistochemistry analyses showed in the hippocampus
115 ± 13 TUNEL-positive cells after SAH compared to 68 ±
8 positive cells in the cerebral cortex (differences between
means 48 ± 15; 𝑃 = 0.014). In control animals, there were
58 ± 10 TUNEL-positive cells in the hippocampus compared
to 36 ± 2 in the cerebral cortex (differences between means
22 ± 9; 𝑃 = 0.13).
A tendency towards increased mean number of fibrino-
gen-positive microvessels in cerebral cortex was noted (9 ±
2 fibrinogen positive cells after SAH compared to 2 ± 1
positive cells in control animals; 𝑃 = 0.06). There was a
significant increase in fibrinogen-positive microvessels in the
hippocampus (9 ± 2 for SAH compared to 2 ± 1 in sham
controls, 𝑃 = 0.03) (Figure 3(b)).
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Table 1: Pathophysiological characteristics of SAH animals (𝑛 = 8)a.
Time point MABP (mmHg) ICP (mmHg) Relative CPP (% of BL) rCBF of both hemispheres (% of BL)
Baseline 68.4 ± 6.1 6.2 ± 1.7 100 100
Peak 69.5 ± 7.8 49.6 ± 11.9∗† 32.3 ± 15.0∗† 36.3 ± 20.3∗†
Steady state 70.3 ± 5.3 19.4 ± 4.3 81.2 ± 9.6 76.8 ± 15.2
Abbreviations: BL = baseline; CPP = cerebral perfusion pressure; ICP = intracranial pressure; MABP = mean arterial blood pressure; rCBF = regional cerebral
blood flow.
aValues are expressed as mean ± SD.
∗Significantly different compared to baseline values (𝑃 < 0.001).
†Significantly different compared to steady-state values (𝑃 < 0.001).
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Figure 2: Microclot formation after induction of subarachnoid hemorrhage. Representative images showing fibrinogen positive vessels
(brown staining; black arrows) in the hippocampus ((a), (c)) and cortex ((b), (d)) after SAH ((a), (b)) and in controls ((c), (d)). Scale bars =
400 𝜇m.
3.3. Correlation between Apoptosis and Microclot Formation.
Therewas no correlation betweenmicroclot formation (num-
ber of fibrinogen positive clots) and apoptosis (number of
TUNEL positive cells) in the cerebral cortex (reg coeff 𝑟 =
0.31, 𝑟2 = 0.094, 𝑃 = 0.3; Figure 3(c)) or the hippocampal
region (reg coeff 𝑟 = 0.45, 𝑟2 = 0.2, 𝑃 = 0.14; Figure 3(d)).
3.4. Correlation between CPP Depletion and Apoptosis Respec-
tively Microclot Formation. CPP showed maximal deple-
tion within the first 3 minutes after induction of SAH
(Figure 3(e)). A significant linear correlation was observed
between CPP reduction within the first three minutes after
SAH and the total number of TUNEL positive cells in the
cortex (reg coeff 𝑟 = 0.73, 𝑟2 = 0.53, 𝑃 = 0.007; Figure 4(a))
as well as in the hippocampus (reg coeff 𝑟 = 0.77, 𝑟2 = 0.60,
𝑃 = 0.003; Figure 4(b)). However, no significant correlation
was detected between relative CPP depletion within the
first three minutes and the number of fibrinogen stained
microvessels in the cortex (reg coeff 𝑟 = 0.42, 𝑟2 = 0.17,
𝑃 = 0.18; Figure 4(c)) or in the hippocampus (reg coeff
𝑟 = 0.47, 𝑟2 = 0.22, 𝑃 = 0.12; Figure 4(d)).
4. Discussion
4.1. Animal Model. In recent years, evidence has indicated
that EBI and DCI largely contribute to the unfavorable out-
come and mortality after aneurysmal SAH [1, 2]. Parenchy-
mal apoptosis and microthrombosis after aneurysmal SAH
are considered to be mainly involved in EBI and contributing
to DCI [10–12]. Although different animal models of SAH
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Figure 3: Evidence of microclot formation, neuronal apoptosis, and CPP depletion after experimental SAH. Quantification of TUNEL-
positive cells and fibrinogen-positive stained microthrombi in cortex and hippocampus. (a) There were significant increases in the number
of TUNEL-positive cells in both cerebral cortex and hippocampus as compared to controls (𝑃 = 0.016 and 𝑃 = 0.017, resp., Student’s 𝑡-test).
(b)There was a nonstatistically significant trend towards an increase in fibrinogen-positive microvessels in the cerebral cortex (𝑃 = 0.06) and
a statistically significant increase in fibrinogen-positive microvessels in the hippocampus (𝑃 = 0.03). No correlations of TUNEL-positivity
with fibrinogen-positivity were observed in cortex (𝑅2 = 0.094; (c)) or in hippocampus (𝑅2 = 0.2; (d)). All data are expressed as mean ±
SEM, 𝑛 = 8 in SAH group, and 𝑛 = 4 in control group. A 𝑃 value of <0.05 was considered statistically significant. (e) Time course of the CPP
depletion after induction of SAH compared to control animals.
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Figure 4: In the SAH group, a significant reduction in CPP was observed within the first three minutes of the phase of maximum depletion
compared to the baseline or the steady state (𝑃 < 0.001). A significant positive linear correlation between the mean CPP during the phase of
maximum depletion after induced SAH and the total number of TUNEL positive cells was found in both the cortex (𝑟2 = 0.53, 𝑃 = 0.007;
(a)) and the hippocampus (𝑟2 = 0.60, 𝑃 = 0.003; (b)). There was no correlation between CPP depletion and fibrinogen positive microvessels
in either cortex (𝑟2 = 0.17, (c)) or hippocampus (𝑟2 = 0.22, (d)). Graphs include the 95% confidence intervals.
exist [9, 13–15], it is important to investigate the impact of
microthrombosis and apoptosis on EBI in animal models
that represent acute pathophysiological features of SAH
such as the endovascular perforation models [16–19] or ICP
controlled blood prechiasmatic injection [20].
The potential important advantage of using a rabbit
aneurysmal SAH model to investigate microthrombosis for-
mation postaneurysmal SAH is the fact that the rabbit
coagulation system is very similar to that in humans [21,
22]. Human-resemblance of larger animals makes them an
attractive tool to provide new insights into the study of
microvascular thrombosis [23, 24].
Furthermore, following aneurysm rupture, there is a
rapid increase in intracranial pressure and consequent
decrease in cerebral perfusion pressure [25]. Cerebral
ischemia caused by increased intracranial pressure and
reduced cerebral blood flow induces severe injury to the
brain tissue and cerebral microvasculature [26]. To take
advantage of the ability to control for ICP increase to
investigate the effect on the mechanisms of cell apoptosis
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and intraparenchymalmicroclot formation, our rabbit model
closely mimics these human pathophysiological features of
aneurysm rupture by arterial blood-inflow into a closed
cranium [7, 8].
4.2. Microclot Formation. Recent studies detected microclots
following aneurysmal SAH in humans and in models such as
mice and rats [5, 19, 27–31]. In a rat model of endovascular
perforation, platelet aggregates were detected in the cerebral
pial microvasculature as early as 10minutes after SAH, reach-
ing a peak at 24 hours, and were undetectable at 48 hours
[32, 33]. For the intraparenchymal microcirculation, platelets
have been shown to aggregate in parenchyma microvessels
within 10 minutes after SAH and persist for up to 24 hours
[34].
It is still unknown whether parenchymal microves-
sels respond the same way as pial vessels [18, 35]. In
our rabbit blood shunt model, the hippocampal brain
parenchyma showed a selective vulnerability to SAH induced
microthrombosis formation within 24 hours. Compared to
the mouse perichiasmatic injection model used by Sabri
et al. [29, 36], they observed a significant increase of
microthrombosis in both the hippocampus and cerebral
cortices. Although brain injury due to aneurysmal SAH
causes global parenchymal damage [37, 38], vulnerability to
subcortical brain regions may differ [39]. This might explain
the SAH-induced significant increase of microthrombosis in
the rabbit brain parenchyma at the hippocampal levels but
not the cortex. Furthermore, the number of animals used in
our study is small, which might explain missing correlation
data in the cortex.
Finally, different mechanisms may contribute to micro-
clot formation. An experimental model of SAH in the rat
showed that a hypercoagulable state occurs immediately after
injury. This abnormality in coagulation profile seemed to
be a response mechanism for the acute traumatic events
caused by induction of SAH in rats andmay predispose them
to microthrombus formation [40]. In humans, elevation of
platelet activating factor and coagulation factors after SAH
has been described [41]. Supporting the idea of microclot for-
mation, markers of hypercoagulation and platelet activation
increase dominantly in CSF and jugular blood compared to
systemic levels after aneurysmal SAH, indicating a cerebral
origin [42]. To sum up, activation of the coagulation cascade,
impaired fibrinolytic activity, and inflammatory processes are
particularly regarded as possible mechanisms for microclot
formation [5], and different coagulation profiles among
various species might be considered for future investigations
regarding microclot formations.
4.3. Brain Apoptosis. Although the exact mechanism of
intravascular coagulation after aneurysmal SAH is unknown,
microclot formation may contribute to decreased cerebral
blood flow, subsequent ischemic injury, and neuronal apop-
tosis supporting the development of DCI [32]. It is still a
matter of debate whether the blood clot itself or the transient
global ischemia after increase of the intracranial pressure is
responsible for the microcirculatory changes after SAH [36].
In our rabbitmodel, 24 hours after SAH-induction,microclot
formation paralleled by apoptotic brain cells marked by
TUNEL was predominantly distributed in the hippocam-
pus, a brain region known to be particularly vulnerable
to transient ischemia [43]. This finding is consistent with
several autopsy studies that detected microclots in small
parenchymal vessels and demonstrated a correlation between
these microclot densities and the location and severity of
histological evidence of ischemia [27]. It is well know that a
brief period of global brain ischemia mainly causes cell death
in hippocampal subfields neurons in rodents and humans,
whereas other neurons are much less vulnerable [44, 45].
Furthermore, microclot formation and neuronal apoptosis
were detected in both hemispheres, indicating a more global
disease after SAH than the effect of local ischemia caused by
microclot formation. InMRI studies in SAHpatients, delayed
ischemic lesions were observed bilaterally, regardless of the
site of aneurysm rupture or vasospasm [46, 47]. Similarly,
microembolic signals detected with transcranial Doppler
(TCD) in 40 patients with aneurysmal SAH were mostly
noted bilaterally and were associated with the development
of cerebral ischemic symptoms and not related to vasospasm
[31]. In an endovascular perforation model in mice, positive
antithrombin staining was detected bilaterally in a scattered
distribution with a peak at 48 hours and then decreased
gradually [30]. However, the disadvantage of this murine
model using endovascular perforation is the uncertainty to
determine if rebleeding occurred over the study time.
4.4. Correlation of Microthrombosis, Neuronal Injury, and
CPP Depletion. CPP shortage during the hyperacute phase
of SAH significantly correlated with the degree of apoptosis
and neurodegeneration in the hippocampus and cortex 24
hours after experimental SAH. However, no significant cor-
relation was found between CPP depletion and the number
of fibrinogen positive microvessels in either the cortex or
the hippocampus. Furthermore, there was no significant
correlation between structural changes inmicrovessels due to
early brain injury comparingTUNEL-positivity neither in the
cortex nor in the hippocampus in our study findings.This is in
contrast to the studies of Sabri et al. [29, 36], where there were
significant correlations of microthrombosis formation and
neuronal apoptosis. One possible explanation might be that
an inflammatory response that accompanies neural injury
has both positive and negative effects [48]. There is extensive
cross talk between inflammation and coagulation, whereby
not only does inflammation lead to activation of coagulation
but coagulation also considerably affects inflammatory activ-
ity [49]. It is known that, within a few hours after neuronal
injury to the central nervous system, numerous neutrophils
induce an inflammatory reaction and express high levels of
the atypical growth factor oncomodulin, a crucial factor for
neuronal regeneration, and cell survival [50]. Inflammation
may also cause neuroprotection via inhibition of apoptosis
after ischemia [51]. However, the exact effects and mech-
anisms of inflammation, microthrombosis, apoptosis, and
neuroprotection in the context of aneurysmal SAH remain
unknown and their temporal interactions need to be analyzed
in further detail.
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To sum up, microthrombosis in the cerebral cortex and
hippocampus in a rabbit model of SAH is an important
finding by itself. To the best of our knowledge, this is the first
time that early microclot formation has been demonstrated
in a rabbit model of SAH. Because rabbits have a coagulation
cascade very similar to that seen in humans [21, 22], these
findings might provide a further piece of the puzzle in our
understanding of pathophysiological aspects taking place
in mammals after SAH and might contribute to successful
translational studies in human trials.
5. Conclusion
This study found evidence of microclot formation and neu-
ronal apoptosis after experimental SAH in a rabbit blood
shunt model. Both microthrombosis and neuronal apoptosis
may contribute to EBI and subsequent DCI in a distinct
pathway. Long-term survival studies are mandatory to fur-
ther analyze the impact and temporal characteristics—as
well as the chronological sequence—of microthrombosis and
apoptosis impact on DCI.
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